ClearPoint Neuro, Inc. (CLPT) Financial Statements (2026 and earlier)

Company Profile

Business Address 120 S. SIERRA AVENUE
SOLANA BEACH, CA 92075
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)
Annual | Quarterly

3/31/2026
MRQ
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments45,92320,10423,14037,48954,10920,099
Cash and cash equivalent45,92320,10423,14027,61554,10920,099
Short-term investments    9,874  
Receivables6,5494,7133,2112,6652,3371,881
Inventory, net of allowances, customer advances and progress billings8,3596,8637,9119,3034,9383,238
Inventory8,3596,8637,9119,3034,9383,238
Contract with customer, asset, after allowance for credit loss 150     
Other undisclosed current assets2,6191,6831,9101,723508244
Total current assets:63,60033,36336,17251,18061,89225,462
Noncurrent Assets
Inventory, Noncurrent  103386450519589
Operating lease, right-of-use asset8,4303,0863,5641,8952,2412,736
Property, plant, and equipment, after accumulated depreciation, depletion, and amortization2,6212,0051,389806539319
Intangible asset, including goodwill, after accumulated amortization21,3944841,0411,028265353
Goodwill7,472     
Intangible asset, excluding goodwill, after accumulated amortization13,9224841,0411,028265353
Other noncurrent assets1,70214810913112559
Total noncurrent assets:34,1475,8266,4894,3103,6894,056
TOTAL ASSETS:97,74739,18942,66155,49065,58129,518
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities8,4027,6754,3935,1613,5682,244
Employee-related liabilities✕✕✕✕✕2,6041,595
Accounts payable1,2561,340393272427300
Accrued liabilities7,1466,3354,0004,889537349
Deferred revenue1,6692,1212,6131,066678562
Customer refund liability    500  
Other undisclosed current liabilities69455742461507394
Total current liabilities:10,76510,3537,4306,7884,7533,200
Noncurrent Liabilities
Long-term debt and lease obligation49,077 9,9499,89311,7772,446
Long-term debt, excluding current maturities49,077 9,9499,8939,838 
Liabilities, other than long-term debt9,8853,4474,1091,922264215
Deferred revenue581436541390264215
Deferred income tax liabilities354     
Other liabilities489     
Operating lease, liability8,4613,0113,5681,5321,9392,446
Other undisclosed noncurrent liabilities      21,280
Total noncurrent liabilities:58,9623,44714,05811,81512,04123,941
Total liabilities:69,72713,80021,48818,60316,79427,141
Equity
Equity, attributable to parent28,02025,38921,17336,88748,7872,377
Common stock294276247246237170
Common stock, value, subscriptions5,641     
Additional paid in capital238,995216,483193,382187,008182,482121,729
Accumulated deficit(216,910)(191,370)(172,456)(150,367)(133,932)(119,522)
Total equity:28,02025,38921,17336,88748,7872,377
TOTAL LIABILITIES AND EQUITY:97,74739,18942,66155,49065,58129,518

Income Statement (P&L) ($ in thousands)
Annual | Quarterly

3/31/2026
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Revenues36,97131,39023,95520,55116,29912,829
Cost of revenue(14,279)(12,268)(10,341)(7,020)(5,008)(3,709)
Gross profit:22,69219,12213,61413,53111,2919,120
Operating expenses(30,395)(24,390)(23,465)(20,505)(17,746)(9,956)
Other undisclosed operating loss(16,461)(14,478)(12,595)(9,358)(6,919)(5,384)
Operating loss:(24,164)(19,746)(22,446)(16,332)(13,374)(6,220)
Nonoperating income (expense)1,067(40)(29)(22)(63)882
Investment income, nonoperating1,213     
Other nonoperating income (expense)(146)(40)(29)(22)(63)882
Interest and debt expense(2,388)  (81)(973)(1,444)
Other undisclosed loss from continuing operations before equity method investments, income taxes      
Loss from continuing operations before equity method investments, income taxes:(25,485)(19,786)(22,475)(16,435)(14,410)(6,782)
Other undisclosed loss from continuing operations before income taxes      
Loss from continuing operations before income taxes:(25,485)(19,786)(22,475)(16,435)(14,410)(6,782)
Income tax expense(55)     
Loss from continuing operations:(25,540)(19,786)(22,475)(16,435)(14,410)(6,782)
Loss before gain (loss) on sale of properties:✕✕✕✕✕(14,410)(6,782)
Net loss:(25,540)(19,786)(22,475)(16,435)(14,410)(6,782)
Other undisclosed net income attributable to parent  872386   
Net loss available to common stockholders, diluted:(25,540)(18,914)(22,089)(16,435)(14,410)(6,782)

Comprehensive Income ($ in thousands)
Annual | Quarterly

3/31/2026
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Net loss:(25,540)(19,786)(22,475)(16,435)(14,410)(6,782)
Comprehensive loss, net of tax, attributable to parent:(25,540)(19,786)(22,475)(16,435)(14,410)(6,782)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: